WASHINGTON, May 15 -- Centers for Medicare & Medicaid Services has issued a notice called: Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request.
The notice was published in the Federal Register on May 15 by Evell J. Barco Holland, Federal Register Liaison, Centers for Medicare & Medicaid Services.
Summary: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' draft guidance for the third cycle of the Medicare Drug Price Negotiation Program, the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price for 2026, 2027, and 2028 for the implementation of the Inflation Reduction Act (IRA)....